2-((2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetic acid;(6?,11?,16?,17?)-6,9-Difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3,20-dioxopregna-1,4-dien-21-oic Acid; 6bH-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxole pregna-1,4-dien-21-oic Acid Deriv.; Fluocinolone Acetonide EP Impurity A;Fluocinolone Acetonide-21-carboxylic Acid; (Fluocinolone Acetonide-21-Carboxylic Acid)
Fluocinolone Acetonide EP Impurity A is a fully characterized chemical compound used as a reference standard of API Fluocinolone Acetonide. The standard offered is compliant with regulatory guidelines. Fluocinolone Acetonide EP Impurity A is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 106931-78-6
